ABOUT US
History
Brief History
Globalization
2025
◆Official establishment of Nangang Operations Headquarters
◆Launch of new CIS corporate identity system
◆First in the nation to integrate pharmaceutical supply chain, founding the inaugural Preventive Medicine Center brand clinic
◆First in the nation to establish a green logistics pharmaceutical plant (collaboration: Nang-Kuang Pharmaceutical × National Cheng Kung University Hospital × PKG Logistics)
2023
◆Celebrated 60th anniversary, revenue surpassed NT$2 billion(NT$2.15 billion)
◆Launched preventive medicine brands: Life Quality Medicine series, Life Style BarX series, and Arvixx Medical Healthcare series
2020
◆Energy Saving Leadership Award and Energy Education Promotion Award of Ministry of Economic Affairs。
◆Certified by ISO 45001 Occupational Health and Safety 。
◆TFDA Routine PIC/S GMP & GDP Certification (Valid until June 11, 2022)。
2018
◆TFDA Routine PIC/S GMP & GDP Certification (Valid until June 11, 2020)。
◆Japan PMDA GMP Certification (Pre-filled syringe line and special dosage line)。
2017
◆US FDA cGMP Certification (Soft bag infusion line)。
2016
The first Taiwanese infusion product (LVP) approved to be launched in the United States.
2015
Sterile parenteral oncology production line and LVP (PP bag for premix solutions) production line passed US FDA inspection.
★Awarded Gold Prize of Outstanding Biotechnology Industries Award 2015.
2014
Prefilled syringe production line passed FDA inspection and CGMP standard.
2013
Passed Excellent company Good Distribution Practice (GDP) Counseling Visit and awarded excellent rating.
Expanded facility, newly built liquid cytotoxic injections and lyophilized sterile products passed PIC/S GMP inspection by MOHW, Executive Yuan of Taiwan.
Lyophilized injections (parenteral products) passed PIC/S GMP.
2012
Signing contracts with listed companies in USA for development and production of drugs for neurological disorders as well as marketing of drugs for hematologic disorders.
2011 .10
The newly established sterile injections production line was approved by TFDA and passed PIC/S GMP.
2010 .08
The whole plant passed the PIC/S GMP inspection by Department of Health.
2009 .01
NANGKUANG passed the certification of Taiwan Intellectual Property Management System (TIPS).
2008 .03
The training of the seed inspectors of Bureau of Food and Drug Analysis by the consultant of Medicines and Healthcare products Regulatory Agency (MHRA) of UK.
2006 .09
Mock inspection of PIC/S GMP by TPDA & Mr. Robert Tribe.
2004 .10
NANGKUANG passed the third stage inspection and evaluation of cGMP-Computer Validation by Department of Health.
2003 .08
NANGKUANG enjoyed the honor to win the Pharmaceutical Technology Research Award of DOH:
Bronze Medal: Non-PVC Soft-bag LVP and other excellent quality products.
Bronze Medal: Stable oral dosages and the preparation methods of Omeprazole or other similar compound, Lansoprazole.
2003 .05
NANGKUANG passed the second stage inspection and evaluation of cGMP-Product Validation by Department of Health.
2003 .03
NANGKUANG passed the cGMP inspection and evaluation -Product Validation by Department of Health.
2002 .07
NANGKUANG was awarded the certificate of type II environment-friendly product-“Containers of injections/Multi-layer film of polyethylene soft bags” by Environment Protection Administration.
2001 .07
NANGKUANG passed the first stage inspection and evaluation of cGMP-Supporting System and Critical Manufacturing Process Validation by Department of Health.
2001 .02
The first company in Taiwan to successfully export LVP/ampoule SVP to Japan. This meant the quality of NK’s products have gained international acceptance.
In the meantime, NANGKUANG started to receive the international OEM/ODM orders.
Growing Stage
2000 .12
NANGKUANG received the National Biotechnology & Medical Care Award of 2000 in "Whole Pharmaceutical Factory" category.
2000 .09
NANGKUANG was granted the patents of Omeprazole and Lansoprazole.
2000 .07
NANGKUANG passed the certification of ISO 9001 (QMS) and ISO 14001 (EMS) Management System (NSF-ISR certification).
1999 .12
NANGKUANG received the National Biotechnology & Medical Care Award of 1999 in “Non-PVC multi-layer polyethylene soft bags” category.
1999 .08
Building the framework of enterprise resource planning system (ERP).
1997 .02
The first pharmaceutical company to introduce the automatic non-PVC soft bags filling machine for LVP from Germany.
1996 .12
The construction of the new factory for parenteral products was completed.
1996 .08
The construction of the new R&D building was completed.
Developing Stage
1995 .01
Planning the automatic warehouse system (AS/RS).
1994 .10
Employ US professional consultants on long-term basis to implement process validation and enhance products quality.
1993 .12
Employ overseas researchers of US to establish the research and development center of extended release oral dosage forms and transdermal dosage forms.
1986 .09
The Investment Review Committee of Ministry of Economic Affairs approved the technical cooperation between NANGKUANG and Kobayashi Pharmaceutical Co., Ltd. of Japan.
1985 .07
NANGKUANG was approved by governmental authority as a GMP pharmaceutical plantand ranked the second among domestic pharmaceutical companies.
1978 .03
NANGKUANG’s Shin-hua factory was established and completed at Shin-hua Town of Tainan County.
Initial Stage
1963 .02
NANGKUANG was established in Tainan City.